LAUREN HODGES: Open Payments
NPI 1760853030 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 82 payments from 14 companies in 2025. Trend: 2023 $2,149 · 2024 $2,202 · 2025 $1,829
Food & beverage: $1,829
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $298 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $253 |
| Amgen Inc. | 12 | $226 |
| Merck Sharp & Dohme LLC | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 6 | $127 |
| E.R. Squibb & Sons, L.L.C. | 6 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Lilly USA, LLC | 5 | $97 |
| PFIZER INC. | 4 | $86 |
Products named: Ozempic, JARDIANCE, REPATHA, LEQVIO, VERQUVO, Kerendia, FARXIGA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
